Non-implementation of new evidence is a longstanding issue in medicine. In critical care, the CHEST(1) and 6S(2) trials identified clear harm with the use of hydroxyethyl starch solutions. Yet, they continued to be widely used until regulatory approval was removed(3) or modified.(4) The PROSEVA trial(5) identified a ~50% absolute mortality reduction from prone-position ventilation in …
Rob Mac Sweeney (Thu,) studied this question.